Investigating immune amnesia after measles virus infection in two West African countries: A study protocol.

"Investigation of Immune Amnesia Following Measles Infection in Select African Regions" (ClinicalTrials.gov Identifier: NCT06153979) is a prospective, observational, longitudinal study being conducted in two West African countries; Guinea and Mali. Acute measles virus (MeV) infection has b...

Full description

Saved in:
Bibliographic Details
Main Authors: Karine Fouth Tchos, Renée Ridzon, Mory Cherif Haidara, Djeneba Dabitao, Esther Akpa, Daouda Camara, David Vallée, Mariam Coulibaly, Sekou Camara, Jamila Aboulhab, Mahamadou Diakité, Bassirou Diarra, Samba Diarra, Ilo Dicko, Alyson Francis, Cécé Francis Kolié, Michel Koropogui, Caeul Lim, Seydou Samaké, Sally Hunsberger, Moussa Sidibé, Ray Y Chen, Issa Konate, Seydou Doumbia, Abdoul Habib Beavogui, Kathryn Shaw-Saliba
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0314828
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839634413018677248
author Karine Fouth Tchos
Renée Ridzon
Mory Cherif Haidara
Djeneba Dabitao
Esther Akpa
Daouda Camara
David Vallée
Mariam Coulibaly
Sekou Camara
Jamila Aboulhab
Mahamadou Diakité
Bassirou Diarra
Samba Diarra
Ilo Dicko
Alyson Francis
Cécé Francis Kolié
Michel Koropogui
Caeul Lim
Seydou Samaké
Sally Hunsberger
Moussa Sidibé
Ray Y Chen
Issa Konate
Seydou Doumbia
Abdoul Habib Beavogui
Kathryn Shaw-Saliba
author_facet Karine Fouth Tchos
Renée Ridzon
Mory Cherif Haidara
Djeneba Dabitao
Esther Akpa
Daouda Camara
David Vallée
Mariam Coulibaly
Sekou Camara
Jamila Aboulhab
Mahamadou Diakité
Bassirou Diarra
Samba Diarra
Ilo Dicko
Alyson Francis
Cécé Francis Kolié
Michel Koropogui
Caeul Lim
Seydou Samaké
Sally Hunsberger
Moussa Sidibé
Ray Y Chen
Issa Konate
Seydou Doumbia
Abdoul Habib Beavogui
Kathryn Shaw-Saliba
author_sort Karine Fouth Tchos
collection DOAJ
description "Investigation of Immune Amnesia Following Measles Infection in Select African Regions" (ClinicalTrials.gov Identifier: NCT06153979) is a prospective, observational, longitudinal study being conducted in two West African countries; Guinea and Mali. Acute measles virus (MeV) infection has been shown to result in a loss of pre-existing immunity (immune amnesia). MeV-induced immune amnesia has not been studied in West Africa where continual MeV outbreaks occur. Additionally previous studies have relied on naturally occurring exposures to viruses to examine the immune systems ability to create antibodies. Thus, the overall goal of this protocol is to investigate the impact of MeV infection on pre-existing immunity to endemic pathogens in West Africa, observe the effect of a subsequent exposure to a novel pathogen (rabies vaccine), and measure the frequency of subsequent healthcare visits. A total of 256 children aged 1-15 years are being enrolled into one of two study arms: those with acute MeV infection (cases) as confirmed by laboratory testing and without (controls). Controls must be immune to MeV (have IgG). Blood samples are collected at multiple time points including screening (Day 0), at an optional visit to repeat IgM serology for inconclusive or negative Day 0 results (Day 7-10), and during follow-up visits on Day 14, Week 13, and Week 52. These blood samples will be tested to evaluate both humoral and cellular immune responses to a panel of viruses, bacteria, and parasites, including pathogens endemic to West Africa. To explore how recent MeV infection may affect the child's ability to respond to a new exposure, all participants will receive a rabies vaccine (as a controlled stimulus) at one of two timepoints post Day 0 visit. Biological samples will be collected after vaccination to assess if the rabies vaccine response differs: 1) between cases and controls, and 2) based on the time since acute MeV infection. In addition, the study team will collect information on healthcare encounters during the year-long follow-up to determine if there is a difference in the number of encounters by study group. The findings of this study will further the understanding of the MeV immune amnesia phenotype by understanding its impact on endemic pathogens and subsequent immune response following infection.
format Article
id doaj-art-4e92216ed87e4819b53d3db2bc7f35d4
institution Matheson Library
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-4e92216ed87e4819b53d3db2bc7f35d42025-07-10T05:31:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01206e031482810.1371/journal.pone.0314828Investigating immune amnesia after measles virus infection in two West African countries: A study protocol.Karine Fouth TchosRenée RidzonMory Cherif HaidaraDjeneba DabitaoEsther AkpaDaouda CamaraDavid ValléeMariam CoulibalySekou CamaraJamila AboulhabMahamadou DiakitéBassirou DiarraSamba DiarraIlo DickoAlyson FrancisCécé Francis KoliéMichel KoropoguiCaeul LimSeydou SamakéSally HunsbergerMoussa SidibéRay Y ChenIssa KonateSeydou DoumbiaAbdoul Habib BeavoguiKathryn Shaw-Saliba"Investigation of Immune Amnesia Following Measles Infection in Select African Regions" (ClinicalTrials.gov Identifier: NCT06153979) is a prospective, observational, longitudinal study being conducted in two West African countries; Guinea and Mali. Acute measles virus (MeV) infection has been shown to result in a loss of pre-existing immunity (immune amnesia). MeV-induced immune amnesia has not been studied in West Africa where continual MeV outbreaks occur. Additionally previous studies have relied on naturally occurring exposures to viruses to examine the immune systems ability to create antibodies. Thus, the overall goal of this protocol is to investigate the impact of MeV infection on pre-existing immunity to endemic pathogens in West Africa, observe the effect of a subsequent exposure to a novel pathogen (rabies vaccine), and measure the frequency of subsequent healthcare visits. A total of 256 children aged 1-15 years are being enrolled into one of two study arms: those with acute MeV infection (cases) as confirmed by laboratory testing and without (controls). Controls must be immune to MeV (have IgG). Blood samples are collected at multiple time points including screening (Day 0), at an optional visit to repeat IgM serology for inconclusive or negative Day 0 results (Day 7-10), and during follow-up visits on Day 14, Week 13, and Week 52. These blood samples will be tested to evaluate both humoral and cellular immune responses to a panel of viruses, bacteria, and parasites, including pathogens endemic to West Africa. To explore how recent MeV infection may affect the child's ability to respond to a new exposure, all participants will receive a rabies vaccine (as a controlled stimulus) at one of two timepoints post Day 0 visit. Biological samples will be collected after vaccination to assess if the rabies vaccine response differs: 1) between cases and controls, and 2) based on the time since acute MeV infection. In addition, the study team will collect information on healthcare encounters during the year-long follow-up to determine if there is a difference in the number of encounters by study group. The findings of this study will further the understanding of the MeV immune amnesia phenotype by understanding its impact on endemic pathogens and subsequent immune response following infection.https://doi.org/10.1371/journal.pone.0314828
spellingShingle Karine Fouth Tchos
Renée Ridzon
Mory Cherif Haidara
Djeneba Dabitao
Esther Akpa
Daouda Camara
David Vallée
Mariam Coulibaly
Sekou Camara
Jamila Aboulhab
Mahamadou Diakité
Bassirou Diarra
Samba Diarra
Ilo Dicko
Alyson Francis
Cécé Francis Kolié
Michel Koropogui
Caeul Lim
Seydou Samaké
Sally Hunsberger
Moussa Sidibé
Ray Y Chen
Issa Konate
Seydou Doumbia
Abdoul Habib Beavogui
Kathryn Shaw-Saliba
Investigating immune amnesia after measles virus infection in two West African countries: A study protocol.
PLoS ONE
title Investigating immune amnesia after measles virus infection in two West African countries: A study protocol.
title_full Investigating immune amnesia after measles virus infection in two West African countries: A study protocol.
title_fullStr Investigating immune amnesia after measles virus infection in two West African countries: A study protocol.
title_full_unstemmed Investigating immune amnesia after measles virus infection in two West African countries: A study protocol.
title_short Investigating immune amnesia after measles virus infection in two West African countries: A study protocol.
title_sort investigating immune amnesia after measles virus infection in two west african countries a study protocol
url https://doi.org/10.1371/journal.pone.0314828
work_keys_str_mv AT karinefouthtchos investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT reneeridzon investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT morycherifhaidara investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT djenebadabitao investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT estherakpa investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT daoudacamara investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT davidvallee investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT mariamcoulibaly investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT sekoucamara investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT jamilaaboulhab investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT mahamadoudiakite investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT bassiroudiarra investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT sambadiarra investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT ilodicko investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT alysonfrancis investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT cecefranciskolie investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT michelkoropogui investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT caeullim investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT seydousamake investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT sallyhunsberger investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT moussasidibe investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT rayychen investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT issakonate investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT seydoudoumbia investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT abdoulhabibbeavogui investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol
AT kathrynshawsaliba investigatingimmuneamnesiaaftermeaslesvirusinfectionintwowestafricancountriesastudyprotocol